4D Molecular Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Emeryville, CA
SEC filing record 1 source field available
Fiscal year end
31 December
4D Molecular Therapeutics, Inc. has filed 421 SEC EDGAR filings since 13 Aug 2015

SEC filing history

Showing 276-300 of 421 matching filings.

Per page
25
Current page
12
4

FORM 4

Filing date
27 Sep 2022
Reporting date
23 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Sep 2022
Reporting date
23 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
27 Sep 2022
Reporting date
23 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-267013

EFFECT filing

Filing date
06 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Sep 2022
Reporting date
01 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Sep 2022
Reporting date
01 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Sep 2022
Reporting date
01 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Sep 2022
Reporting date
01 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
01 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
30 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-267013

S-3

Filing date
23 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
27 Jun 2022
Reporting date
16 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Jun 2022
Reporting date
18 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91921

AMENDMENT NO. 1 TO SCHEDULE 13G

Filing date
21 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 May 2022
Reporting date
23 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 May 2022
Reporting date
23 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 May 2022
Reporting date
23 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 May 2022
Reporting date
23 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 May 2022
Reporting date
23 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 May 2022
Reporting date
23 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .